Skip to content
Stox
Home Results Super 30 Pricing Sign InRegister
Stox
MUKKA - Mukka Proteins Limited
Market Cap: ₹ 965 Cr   |   P/E: 18.5
LTP: ₹ -   |   Pledge %: 0
📊 Quarterly Results 📘 Annual Results 👥 Shareholding Pattern 📈 Technical Analysis
AI PROJECTION 90-Day Outlook
Target price (90d)
₹30.30
Expected return
+15.81%
Confidence band
-3.8%◐ +33.0%+35.2%
Target measured from ₹26.16 on the result date, vs the last traded price that leaves -5.8%.
HISTORICAL Post-Result Price Performance
Return so far since result
▲+33.04%
Window still open — 32 of 90 days elapsed since the result date.
📅 Window: 12 Aug 26 → 10 Nov 26
Model-generated estimate and historical price data, shown for information only — not investment advice. A projection is not a promise: the target and band are machine-learning output on public data and the price may do something else entirely. CryoSim is not a SEBI-registered investment adviser. Past performance does not indicate future results.
📊 Rolling Returns 15 days : 28.4 % 3 months : 41 % 6 months : 47 % 1 year : 16.3 %

Quarterly Results (Consolidated)

Date of Result12 Aug 202615 May 202602 May 202612 Nov 202513 Aug 202515 May 202514 Feb 202515 Nov 202414 Aug 202415 May 202428 Mar 2024
Reported QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
Sales489.65380.6653.5244.58170.77381.57303.15149.19172.5256.7516.99
Other Income1.5915.194.9362.554.155.83.142.854.736.18
Expenses462.92367.04626.65240.86170.52365.53276.5152.11169.63234.47507.44
Profit Before Tax28.3228.7631.789.722.8120.1932.450.235.7226.9615.73
TaxExpense8.747.537.372.390.776.16.17-0.420.28-2.25.4
Net Profit18.6321.3627.256.881.591426.81.475.2629.1512.07
Basic EPS in ₹0.630.690.790.20.050.450.880.070.141.20.48
Total Income491.24395.79658.43250.58173.32385.72308.95152.33175.35261.43523.17
Operating Profit26.7313.5626.853.720.2516.0426.65-2.922.8722.239.55
OPM%5.463.564.111.520.154.28.79-1.961.668.661.85
Sales QoQ %28.65-41.76167.1943.22-55.2525.87103.2-13.51-32.8-50.35-
Sales YoY %186.73-0.25115.5763.94-148.64-41.36----
Net Profit QoQ %-12.78-21.61296.08332.7-88.64-47.761723.13-72.05-81.96141.51-
Net Profit YoY %1071.752.571.68368.03-69.77-51.97122.04----
Operating Profit QoQ %97.12-49.5621.771388-98.44-39.811012.67-201.74-87.09132.77-
Operating Profit YoY %10592-15.460.75227.4-91.29-27.85179.06----
OPM% QoQ %53.37-13.38170.39913.33-96.43-52.22548.47-218.07-80.83368.11-
OPM% YoY %3540-15.24-53.24177.55-90.96-51.5375.14----

Annual Results (Consolidated)

Date of Result15 May 202615 May 202515 May 2024
Reported QuarterMar 2026Mar 2025Mar 2024
Sales1449.451006.421379.83
Other Income28.6815.1219.42
Expenses1405.06962.331311.79
Profit Before Tax73.0859.287.46
TaxExpense18.0612.1713.15
Net Profit57.0948.174.31
Basic EPS in ₹1.741.553.1
Operating Profit44.3944.0968.04
OPM%3.064.384.93
ROCE%8.891017.18
ROE%11.4410.9118.76
Debt to Equity1.541.020.91
Sales YoY %44.02-27.06-
Net Profit YoY %18.69-35.27-
Operating Profit YoY %0.68-35.2-
OPM% YoY %-30.14-11.16-
Debt to Equity (screener)1.56111.02720.9217
Borrowings (screener)779453365
Equity (screener)499441396
de_sourcescreenerscreenerscreener

Shareholding Pattern

Date of Report18 Jul 202616 Apr 202606 Mar 202621 Jul 202511 Apr 202516 Jan 202519 Oct 202411 Jul 202418 Apr 2024
Pledge %000000000
Promoters73.3373.3373.3373.3373.3373.3373.3373.3373.33
FIIs4.664.584.585.367.577.566.8213.8519.04
DIIs000.171.871.981.9822.52
Public26.6726.6726.6726.6726.6726.6726.6726.6726.67
Public QoQ %00000000-
Public YoY %00000----
DIIs QoQ %0-0.17-1.7-0.110-0.02-0.50.5-
DIIs YoY %-1.87-1.98-1.81-0.63-0.02----
FIIs QoQ %0.080-0.78-2.210.010.74-7.03-5.19-
FIIs YoY %-0.7-2.99-2.98-8.49-11.47----
Promoters QoQ %00000000-
Promoters YoY %00000----
Privacy Policy Terms of Use Disclaimer Contact
Disclaimer: Informational only. Not investment advice. Stox is generated using machine-learning models on public data; CryoSim is not a SEBI-registered investment adviser and does not offer personalized investment advice or recommendations. Do your own research and consult a SEBI-registered adviser before making any investment decision. Stox is not liable for any financial losses or market risks.
© 2026 Stox. All rights reserved.